bladder cancer
Conditions
Interventions
1) Urine specimen In patients with bladder cancer, urine should be collected at the time of diagnosis, when postoperative recurrence is confirmed, before and after surgery during hospitalization for
Sponsors
St.Marianna University School of Medicine
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients who are able to collect urine 1) Patients with bladder cancer: diagnosed by various imaging tests, urine cytology, and cystoscopy 2) Patients with benign diseases not accompanied by infection: benign prostatic hyperplasia, ureteral stones, etc. 3) Normal patients: Patients with no obvious organic urological disease such as kidney transplant donors 4) Patients with urinary tract infection: pyelonephritis, cystitis, prostatitis 5) Patients with urological cancer other than bladder cancer: prostate cancer, testicular cancer, renal cell carcinoma
Exclusion criteria
Exclusion criteria: 1) Patients undergoing treatment for malignant diseases in other departments 2) Patients who are judged by the principal investigator to be unsuitable as subjects. 3) Patients who have expressed their intention not to cooperate in this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Exosomes extracted from urine samples will be analyzed using the ExoScreen method to evaluate the difference in expression of specific exosomes between bladder cancer patients and non-cancer patients. | — |
Secondary
| Measure | Time frame |
|---|---|
| In immunohistochemical staining using surgical specimens, the expression of target substances in cancer tissues, mainly nucleic acids and proteins including miRNAs, will be compared with the expression in non-cancerous tissues. | — |
Countries
Japan
Contacts
Public ContactWataru Usuba
St.Marianna University School of Medicine Department of Urology
Outcome results
None listed